Global Cord Blood (CO) Reaches New 1-Year Low at $5.87

Share on StockTwits

Shares of Global Cord Blood Corp (NYSE:CO) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $5.87 and last traded at $6.02, with a volume of 12481 shares changing hands. The stock had previously closed at $6.10.

The firm has a market cap of $731.74 million, a PE ratio of 20.07 and a beta of 0.54.

Global Cord Blood (NYSE:CO) last released its quarterly earnings results on Tuesday, November 27th. The medical research company reported $0.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.11 by ($0.03). Global Cord Blood had a net margin of 24.77% and a return on equity of 7.53%. The company had revenue of $35.98 million for the quarter.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CO. Renaissance Technologies LLC boosted its stake in shares of Global Cord Blood by 14.5% in the third quarter. Renaissance Technologies LLC now owns 2,612,000 shares of the medical research company’s stock worth $18,258,000 after acquiring an additional 331,600 shares during the period. PEAK6 Investments LLC bought a new position in shares of Global Cord Blood in the third quarter worth about $694,000. Panagora Asset Management Inc. boosted its stake in shares of Global Cord Blood by 6,962.3% in the third quarter. Panagora Asset Management Inc. now owns 40,467 shares of the medical research company’s stock worth $283,000 after acquiring an additional 39,894 shares during the period. United Services Automobile Association boosted its stake in shares of Global Cord Blood by 6.3% in the second quarter. United Services Automobile Association now owns 265,800 shares of the medical research company’s stock worth $2,522,000 after acquiring an additional 15,800 shares during the period. Finally, GSA Capital Partners LLP bought a new position in Global Cord Blood during the second quarter valued at approximately $114,000. 16.02% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Global Cord Blood (CO) Reaches New 1-Year Low at $5.87” was first posted by Equities Focus and is the sole property of of Equities Focus. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.equitiesfocus.com/2018/12/08/global-cord-blood-co-reaches-new-1-year-low-at-5-87.html.

About Global Cord Blood (NYSE:CO)

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

See Also: What is a Derivative?

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply